Cubist Systematic Strategies’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-12,316
| Closed | -$13.8K | – | 3246 |
|
|
2025
Q2 | $13.8K | Buy |
12,316
+2,408
| +24% | +$2.94K | ﹤0.01% | 2836 |
|
|
2025
Q1 | $11.4K | Sell |
9,908
-20,240
| -67% | -$37.6K | ﹤0.01% | 2761 |
|
|
2024
Q4 | $184K | Buy |
+30,148
| New | +$358K | ﹤0.01% | 2593 |
|
|
2024
Q3 | – | Sell |
-3,300
| Closed | -$22.7K | – | 3215 |
|
|
2024
Q2 | $22.7K | Buy |
+3,300
| New | +$28.2K | ﹤0.01% | 2764 |
|
|
2023
Q3 | – | Sell |
-10,500
| Closed | -$96.9K | – | 3618 |
|
|
2023
Q2 | $96.9K | Buy |
10,500
+8,311
| +380% | +$93.1K | ﹤0.01% | 2998 |
|
|
2023
Q1 | $30.1K | Buy |
+2,189
| New | +$45.3K | ﹤0.01% | 3631 |
|
|
2022
Q4 | – | Sell |
-19,801
| Closed | -$450K | – | 4402 |
|
|
2022
Q3 | $450K | Sell |
19,801
-2,599
| -12% | -$52.5K | ﹤0.01% | 3244 |
|
|
2022
Q2 | $404K | Buy |
22,400
+14,093
| +170% | +$251K | ﹤0.01% | 3225 |
|
|
2022
Q1 | $222K | Sell |
8,307
-25,140
| -75% | -$468K | ﹤0.01% | 3000 |
|
|
2021
Q4 | $981K | Buy |
33,447
+27,859
| +499% | +$1.38M | 0.01% | 1933 |
|
|
2021
Q3 | $367K | Buy |
+5,588
| New | +$428K | ﹤0.01% | 2229 |
|
|
2021
Q2 | – | Sell |
-5,284
| Closed | -$405K | – | 2986 |
|
|
2021
Q1 | $405K | Sell |
5,284
-2,322
| -31% | -$211K | 0.01% | 2078 |
|
|
2020
Q4 | $672K | Buy |
7,606
+3,425
| +82% | +$241K | 0.01% | 1616 |
|
|
2020
Q3 | $309K | Buy |
+4,181
| New | +$247K | ﹤0.01% | 1976 |
|
|
2019
Q4 | – | Sell |
-5,306
| Closed | -$94K | – | 2471 |
|
|
2019
Q3 | $94K | Buy |
+5,306
| New | +$107K | ﹤0.01% | 1949 |
|
Other funds holding IGMS
Cubist Systematic Strategies's IGMS Position: Q3 2025 in Review
Cubist Systematic Strategies sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 12,316 shares — an estimated $13.8K sold.
Cubist Systematic Strategies first reported a position in IGMS in Q3 2019 and held it in 15 quarters. The position peaked at $981K in Q4 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Cubist Systematic Strategies reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 12,316 IGM Biosciences shares in Q3 2025, an estimated $13.8K.
- Cubist Systematic Strategies first reported a position in IGM Biosciences in Q3 2019 and held it in 15 quarters.
- Cubist Systematic Strategies's IGM Biosciences position peaked at $981K in Q4 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.